Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer

World Journal of Surgery

Volumn 27, Issue 7, 2003, Pages 832-837

  Eisbruch, Avraham ^a   Ship, Jonathan A ^b   Dawson, Laura A ^a   Kim, Hyungjin M ^c   Bradford, Carol R ^c   Terrell, Jeffrey E ^c   Chepeha, Douglas B ^c   Teknos, Theodore N ^c   Hogikyan, Norman D ^c   Anzai, Yoshimi ^a   Marsh, Lon H ^a   Ten Haken, Randall K ^a   Wolf, Gregory T ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HISTOGRAM; HUMAN; PAROTID GLAND; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SALIVARY GLAND; SALIVATION; TREATMENT PLANNING; TUMOR RECURRENCE; XEROSTOMIA;

COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; NECK DISSECTION; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; SALIVARY GLANDS; SURVIVAL RATE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0042931224     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7105-6     Document Type: Article

References (33)

1. Cooper JS, Fu K, Marks J, et al. Late effects of radiation therapy in the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:1141-1164
2. Harrison LB, Zelefski MJ, Pfitzer DG, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck 1997;19:169-175
3. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow up study 7 to 11 years after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1994;28:847-856
4. Jensen AB, Hanse O, Jorgensen K, et al. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol. 1994;33:487-491
5. Beeken L, Calman F. A return to normal eating after curative treatment for oral cancer: long term prospects. Oral Oncol. Eur. J. Cancer 1994;6:387-392
6. Johnson JT, Ferretti GA, Nethery WJ. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N. Engl. J. Med. 1993;329:390-395
7. McDonald S, Meyerowitz C, Smudzin T, et al. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int. J. Radiat. Biol. 1994;29:747-754
8. Brizel D, Sauer R, Wannemacher M, et al. Randomized phase III trial of radiation + Amifostine in patients with head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:224
9. Marsh R, Balter J, Evans VL, et al. Design and analysis of an immobilization and repositioning system for treatment of neck malignancies. Med. Dosimetry 1997;22:293-297
10. Ten Haken RK, Thornton AF, Sandler HM, et al. A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors. Radiother. Oncol. 1992;25:121-133
11. Mancusso AA. Imaging in patients with head and neck cancer. In Million RR, Cassisi NJ, editors, Management of Head and Neck Cancer Philadelphia, JB Lippincott, 1994;43-59
12. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int. J. Radiat. Oncol. Biol. Phys. 1996;36:469-480
13. Million, RR, NJ, Cassisi, Mancuso, AA et al. Management of the neck for squamous cell carcinoma. In Million, RR, Cassisi, NJ, editors, Management of Head and Neck Cancer, 2nd edition, Philadelphia, JB Lippincott, 1994;101
14. Fraas BA, Marsh LM, Watson BA, et al. Optimization and clinical use of multisegment intensity modulation for high dose conformal therapy. Semin. Radiat. Oncol. 1999;9:60-77
15. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:559-568
16. Martel MK, Eisbruch A, Lawrence TS, et al. Cord dose from standard head and neck treatments: implications for conformal treatment plans. Radiother. Oncol. 1998;47:185-189
17. Kessler ML, Kim JJH, McShan DL. A general framework for interactive and automated treatment plan optimization: part I. Evaluators, modifiers, and costlets. Med. Phys. 1998;25:118
18. McShan DL, Fraas BA, Kessler ML. Intensity modulation using beamlets. Med. Phys. 1998;25:149
19. Ship JA, Fox PC, Baum BJ. How much saliva is enough? Normal function defined. J. Am. Dent. Assoc. 1991;122:63-69
20. Jones RE, Takeuchi T, Eisbruch A, et al. Ipsilateral parotid sparing study in head and neck cancer patients receiving radiation therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996;81:642-648
21. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measure of salivary gland performance. J. Am. Dent. Assoc. 1987;115:581-584
22. Zimmerman RP, Mark RJ, Tran LM, et al. Concomitant pilocarpin during head and neck irradiation is associated with decreased post-treatment xerostomia. Int. J. Radiat. Onco. Biol. Phys. 1997;37:571-575
23. Terrell JE, Nanavati KA, Esclamado RM, et al. Head and neck cancer specific quality of life: Instrument validation. Arch. Otolaryngol. Head Neck Surg. 1997;123:1125-1132
24. Eisbruch A, Kim HM, Ten Haken R, et al. Dose, volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. (in press)
25. Eisbruch A, Terrell J, Kim M, et al. Assessment of xerostomia-related quality of life in head and neck cancer patients receiving comprehensive radiation using parotid sparing techniques. Head Neck 1998;20:452
26. Leslie MD, Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother. Oncol. 1994;30:26-32
27. Marks JE, Davis CC, Gottsman VL, et al. The effects of radiation on parotid salivary function. Int. J. Radiat. Oncol. Biol. Phys. 1981;7:1013-1019
28. Franzen L, Funegard U, Ericson T, et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Eur. J. Cancer 1992;28:457-462
29. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997;39:841-848
30. Nowak P, van Dieren E, van der Est H, et al. Treatment portals for elective radiotherapy of the neck: an inventory in the Netherlands. Radiother. Oncol. 1997;43:81-86
31. Nowak P. Elective irradiation of the neck: a three dimensional CT definition of the target for conformal radiotherapy, Doctoral Thesis. Dr. Daniel van Hoed Cancer Center, Erasmus University, Rotterdam, the Netherlands, 1997
32. Hayman LA, Taber KH, Diaz-Marchan PJ, et al. Spatial compartments of the neck. Int. J. Neuroradiol. 1998;4:233-239
33. Pigott K, Dische S, Saunders MI. Where exactly does failure occur after radiation in head and neck cancer? Radiother. Oncol. 1995;37:17-19